Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.95 (-0.25) | AIM:£2.29 (-0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729